Timely versus delayed early childhood vaccination and seizures

Pediatrics

Volumn 133, Issue 6, 2014, Pages

  Hambidge, Simon J ^a,b,c,d   Newcomer, Sophia R ^a   Narwaney, Komal J ^a   Glanz, Jason M ^a,d   Daley, Matthew F ^a,c   Xu, Stan ^a   Shoup, Jo Ann ^a   Rowhani Rahbar, Ali ^e   Klein, Nicola P ^f   Lee, Grace M ^g,h   Nelson, Jennifer C ⁱ   Lugg, Marlene ^b   Naleway, Allison L ^j   Nordin, James D ^k   Weintraub, Eric ^l   DeStefano, Frank ^l  

^a Kaiser Permanente Colorado   (United States)

^b Department of Community Health Services Denver Health ^*  (United States)

^c Children's Hospital Colorado   (United States)

^d Global Health and Health Disparities   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f KAISER PERMANENTE   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h BOSTON CHILDREN S HOSPITAL   (United States)

ⁱ GROUP HEALTH RESEARCH INSTITUTE   (United States)

^j CENTER FOR HEALTH RESEARCH   (United States)

^k HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

^l NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

more..

Author keywords

Immunization; Seizures; Vaccine; Vaccine delay; Vaccine safety

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MEASLES MUMPS RUBELLA VACCINE; MUMPS RUBELLA VACCINE; PNEUMOCOCCUS VACCINE; ROTAVIRUS VACCINE;

ARTICLE; CASE STUDY; CHILD; CHILD HEALTH CARE; COHORT ANALYSIS; CONTROLLED STUDY; EARLY CHILDHOOD INTERVENTION; HUMAN; INFANT; PRIORITY JOURNAL; RISK ASSESSMENT; SEIZURE; THERAPY DELAY; TIME TO TREATMENT; VACCINATION; VACCINATION REACTION;

IMMUNIZATION; SEIZURES; VACCINE; VACCINE DELAY; VACCINE SAFETY;

AGE FACTORS; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INCIDENCE; INFANT; MALE; MEASLES-MUMPS-RUBELLA VACCINE; RISK FACTORS; SEIZURES; UNITED STATES;

EID: 84901828874     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-3429     Document Type: Article

References (40)

1. IOM (Institute of Medicine). Adverse Effects of Vaccines: Evidence and Causality. Washington, DC: The National Academies Press; 2011
2. IOM (Institute of Medicine). The Childhood Immunization Schedule and Safety Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press; 2013
3. DeStefano F. Vaccines and autism: evidence does not support a causal association. Clin Pharmacol Ther. 2007;82(6):756-759 (Pubitemid 350114826)
4. Dempsey AF, Schaffer S, Singer D, Butchart A, Davis M, Freed GL. Alternative vaccination schedule preferences among parents of young children. Pediatrics. 2011;128(5):848-856
5. Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices (ACIP) Recommended Immunization Schedules for Persons Aged 0 Through 18 years and Adults Aged 19 Years and Older - United States, 2013. MMWR 2013;62(Suppl 1):1-19
6. Glanz JM, McClure DL, Magid DJ, et al. Parental refusal of pertussis vaccination is associated with an increased risk of pertussis infection in children. Pediatrics. 2009;123(6):1446-1451
7. Glanz JM, McClure DL, Magid DJ, Daley MF, France EK, Hambidge SJ. Parental refusal of varicella vaccination and the associated risk of varicella infection in children. Arch Pediatr Adolesc Med. 2010;164(1):66-70
8. Glanz JM, McClure DL, O'Leary ST, et al. Parental decline of pneumococcal vaccination and risk of pneumococcal related disease in children. Vaccine. 2011;29(5):994-999
9. Rowhani-Rahbar A, Fireman B, Lewis E, et al. Effect of age on the risk of fever and seizures following immunization with measles-containing vaccines in children. JAMA Pediatr. 2013;167(12):1111-1117
10. Kennedy AM, Brown CJ, Gust DA. Vaccine beliefs of parents who oppose compulsory vaccination. Public Health Rep. 2005;120(3):252-258 (Pubitemid 40631534)
11. Kennedy A, Basket M, Sheedy K. Vaccine attitudes, concerns, and information sources reported by parents of young children: results from the 2009 HealthStyles survey. Pediatrics. 2011;127(suppl 1):S92-S99
12. Salmon DA, Moulton LH, Omer SB, DeHart MP, Stokley S, Halsey NA. Factors associated with refusal of childhood vaccines among parents of school-aged children: a case-control study. Arch Pediatr Adolesc Med. 2005;159(5):470-476 (Pubitemid 40632138)
13. Mills E, Jadad AR, Ross C, Wilson K. Systematic review of qualitative studies exploring parental beliefs and attitudes toward childhood vaccination identifies common barriers to vaccination. J Clin Epidemiol. 2005;58(11):1081-1088 (Pubitemid 41441694)
14. Niederhauser VP, Markowitz M. Barriers to immunizations: Multiethnic parents of under- and unimmunized children speak. J Am Acad Nurse Pract. 2007;19(1):15-23
15. Glanz JM, Newcomer SR, Narwaney KJ, et al. A population-based cohort study of undervaccination in 8 managed care organizations across the United States. JAMA Pediatr. 2013;167(3):274-281
16. Klein NP, Fireman B, Yih WK, et al Vaccine Safety Datalink. Measles-mumps-rubellavaricella combination vaccine and the risk of febrile seizures. Pediatrics. 2010;126(1). Available at: www.pediatrics.org/cgi/content/ full/126/1/e1
17. Barlow WE, Davis RL, Glasser JW, et al Centers for Disease Control and Prevention Vaccine Safety Datalink Working Group. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med. 2001;345(9):656-661
18. Davis RL, Barlow W. Placing the risk of seizures with pediatric vaccines in a clinical context. Paediatr Drugs. 2003;5(11):717-722 (Pubitemid 37452621)
19. Kuter BJ, Brown ML, Hartzel J, et al; Study Group for ProQuad. Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad). Hum Vaccin. 2006;2(5):205-214 (Pubitemid 44786802)
20. Measles, mumps, rubella, and varicella virus live lyophilized preparation for subcutaneous injection (package insert). Issued August 2011 by Merck & Co., Inc., Whitehouse Station, New Jersey. Available at: www.fda.gov/downloads/ BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM123796.pdf. Accessed April 6, 2014
21. Food and Drug Administration. CBER clinical review of studies submitted in support of licensure of Proquad™. 2005. Available at: www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ ucm123800.pdf. Accessed June 4, 2013
22. Baggs J, Gee J, Lewis E, et al. The Vaccine Safety Datalink: a model for monitoring immunization safety. Pediatrics. 2011;127(suppl 1):S45-S53
23. Luman ET, Barker LE, Shaw KM, McCauley MM, Buehler JW, Pickering LK. Timeliness of childhood vaccinations in the United States: days undervaccinated and number of vaccines delayed. JAMA. 2005;293(10):1204-1211 (Pubitemid 40327906)
24. Sun Y, Christensen J, Hviid A, et al. Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type B. JAMA. 2012;307(8):823-831
25. Shui IM, Shi P, Dutta-Linn MM, et al Vaccine Safety Datalink Research Team. Predictive value of seizure ICD-9 codes for vaccine safety research. Vaccine. 2009;27(39):5307-5312
26. Farrington CP, Nash J, Miller E. Case series analysis of adverse reactions to vaccines: a comparative evaluation. Am J Epidemiol. 1996;143(11):1165-1173 (Pubitemid 26158114)
27. Rowhani-Rahbar A, Klein NP, Dekker CL, et al Risk Interval Working Group of the Clinical Immunization Safety Assessment Network. Biologically plausible and evidence-based risk intervals in immunization safety research. Vaccine. 2012;31(1):271-277
28. Shui IM, Baggs J, Patel M, et al. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA. 2012;307(6):598-604
29. Virtanen M, Peltola H, Paunio M, Heinonen OP. Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination. Pediatrics. 2000;106(5). Available at: www.pediatrics.org/cgi/content/full/106/ 5/e62
30. Xu S, Gargiullo P, Mullooly J, McClure D, Hambidge S, Glanz J. Fitting parametric and semi-parametric conditional Poisson regression models with Cox's partial likelihood in self-controlled case series and matched cohort studies. Journal of Data Science. 2010;8:349-360
31. Huang WT, Gargiullo PM, Broder KR, et al Vaccine Safety Datalink Team. Lack of association between acellular pertussis vaccine and seizures in early childhood. Pediatrics. 2010;126(2):263-269
32. Nelson JC, Yu O, Dominguez-Islas CP, et al. Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety study. Am J Epidemiol. 2013;177(2):131-141
33. Tse A, Tseng HF, Greene SK, Vellozzi C, Lee GM; VSD Rapid Cycle Analysis Influenza Working Group. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011. Vaccine. 2012;30(11):2024- 2031
34. Waruiru C, Appleton R. Febrile seizures: an update. Arch Dis Child. 2004;89(8):751-756
35. Jones T, Jacobsen SJ. Childhood febrile seizures: overview and implications. Int J Med Sci. 2007;4(2):110-114 (Pubitemid 46640657)
36. Gasparoni A, Ciardelli L, Avanzini A, et al. Age-related changes in intracellular TH1/TH2 cytokine production, immunoproliferative T lymphocyte response and natural killer cell activity in newborns, children and adults. Biol Neonate. 2003;84(4):297-303 (Pubitemid 37356743)
37. Defay F, De Serres G, Skowronski DM, et al. Measles in children vaccinated with 2 doses of MMR. Pediatrics. 2013;132(5). Available at: www.pediatrics.org/cgi/content/full/132/5/e1126
38. Yetman RJ, Shepard JS, Duke A, et al. Concomitant administration of hepatitis A vaccine with measles/mumps/rubella/varicella and pneumococcal vaccines in healthy 12- to 23-month-old children. Hum Vaccin Immunother. 2013;9(8):1691-1697
39. Halperin SA, Tapiéro B, Dionne M, et al. Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovisur, haemophilus influenza type b, hepatitis b vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2014;33(1):73-80
40. Jacobsen SJ, Ackerson BK, Sy LS, et al. Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting. Vaccine. 2009;27(34):4656-4661